Portfolio: Investments
Epizyme, Inc.
Second generation epigenetic drug discovery and development company
ForteBio, Inc.
Protein quantification and kinetics
Idenix Pharmaceuticals, Inc.
Anti-HIV and HBV therapy
iPierian
Drug discovery and development company harnessing cellular reprogramming breakthroughs
Kalidex
Developing next-generation, broad-spectrum antibiotics for the treatment of serious infections
KaloBios Pharmaceuticals, Inc.
Therapeutic antibody development